Following the New England compounding pharmacy errors that occurred this year and resulted in dozens of deaths and hundreds of injuries due to tainted steroid injections, there are several new regulations aimed at increasing oversight of Massachusetts pharmacies.
Some believe that the deadly meningitis outbreak could have been prevented if the state’s pharmacy board enforced Massachusetts’s existing regulations. Because Massachusetts has strict regulations, the state Board of Pharmacy, as well as the FDA, could have gone into the New England Compounding Center (NECC) to inspect it based on its previous violations of regulations. If the state or federal organizations would have done that, NECC may have been shut down – preventing this national fungal meningitis outbreak.
Contaminated Injections Lead to New State Regulations
The state board that governs pharmacies has set up new regulations requiring pharmacists to report any incidents involving their medications that may be adverse. Also, new regulations require all pending criminal charges against pharmacists to be reported to the state board. Additionally, the new regulations the Massachusetts Board of Pharmacy established require compounding pharmacies to report the volume of medications they are manufacturing.
The new rules are put in place to tighten oversight and keep consumers safe. But others still say that Massachusetts should adopt regulations to oversee out-of-state pharmacies selling medications in the state – requiring them to register with the state of Massachusetts.
State public health officials are reviewing pharmacists’ comments and requests and may revise these new regulations. Our pharmacy error attorneys at Kennedy Hodges, L.L.P. will keep you updated on any changes.
If you were injured by a medication mishap, please call us at 888-526-7616 for a free consultation today. Don’t delay calling, as some states have different pharmacy laws and strict statutes of limitations to file suits for negligence and pharmacy malpractice.